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Abstract 
The sustained and moderate elevation of intraocular pressure, which can be 
initiated at precise time points, remains the cornerstone of research into the 
mechanisms of glaucomatous retinal damage. We focus on the use of 
microbeads to block the outflow of aqueous following anterior chamber 
injection in a range of animals (mouse, rat and primate). We describe some of 
the most commonly used parameters and present guidance on injection 
technique and bead manipulation to maximize the successful generation of 
experimental glaucoma.
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1.0 Introduction 
 The study of glaucomatous pathophysiology has relied on the 
development of technologies to generate sustained and moderate increases 
in intraocular pressure in a range of species. The chronic elevation of 
intraocular pressure (IOP) presents significant challenges in small eyes where 
ocular tissues are thin and vulnerable to the effects of inflammation and 
remodeling. 
 
 The choice of animal is guided by cost, handling characteristics and the 
availability of mutant strains. Not surprisingly, rodents have superseded 
primates as the most common experimental model for the investigation of 
mechanism underlying retinal ganglion cell loss. For the rat, the injection of 
hypertonic saline for the sclerosis of episcleral vessels has been one of the 
most successful models (Morrison et al., 2008) but its use has been 
constrained by need for a high level of surgical skill to cannulate small 
episcleral veins. With the mouse, genetic models of glaucoma such as the 
DBA2J strain which rely on the deposition of pigment cells within the 
trabecular meshwork (TM) (John et al., 1998) have the advantage that they do 
not require surgical intervention for the development of ocular hypertension. 
However, the model incurs significant financial and time costs since animals 
have to be aged before glaucoma develops and control of IOP at the single 
animal level can be problematic (John, 2005). Other models in which the 
episcleral vessels are cauterized externally raise the possibility of the 
confounding effects of increases in episcleral venous pressure (Vecino and 
Sharma, 2011). 
 
 A cost effective model would be one in which the induction of IOP 
elevation is technically undemanding, rapid in onset and works in as many 
animals as possible.  In the last decade the availability of high quality 
microbeads with diameters that match the pores in the TM has facilitated the 
generation of sustained ocular hypertension in primates and rodents. With 
these methods, the onset of ocular hypertension can be timed and the level of 
the IOP increase controlled. In this review we cover the salient features of 
currently used models with technical advice on methods of bead delivery. 
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2.0 Background 
      Obstruction of the TM by the injection of microparticles has a long track 
record as a method for the generation of experimental glaucoma. Some of the 
earliest attempts were based on primate models in which glutaraldehyde 
treated autologous red blood cells were injected into the anterior chamber.  
These cells mimicked the ghost red blood cells (GBCs) in their occlusion of 
the TM by virtue of their membrane rigidity. Sustained elevation in IOP could 
be achieved in both rabbit and primates (Squirrel and Cynomolgous monkeys) 
(Quigley and Addicks, 1980) and electron microscopy revealed considerable 
numbers of deformed GBCs trapped within the TM. While the injection 
technique was straightforward, it was limited in that peak IOP increase could 
be difficult to control and tended to be high (mean IOP in primates of 53.5 
mmHg, mean peak of 69.8 mmHg). At these IOP levels corneal edema was a 
common feature which could confound the accurate measurement of IOP 
because of the increases in corneal thickness. The mean and peak values 
were lower for the rabbit eyes but corneal ectasia was a significant side effect. 
Furthermore, for a sustained increase in IOP almost 75% of the anterior 
chamber had to be filled with red blood cells which could compromise 
fundoscopy. While this model resulted in retinal ganglion cell loss, it had 
greater relevance for the study of retinal ganglion cell death in acute, rather 
than chronic, glaucoma. 
 
In light of these considerations, subsequent primate glaucoma models 
relied on laser treatment of the TM. The appeal of this approach was that it 
resulted in moderate increases in IOP which could be titrated and the laser 
treatment repeated to achieved the desired increase in IOP (Gaasterland and 
Kupfer, 1974). The method has been used for many of the key studies 
outlining early pathological damage in glaucoma (Quigley, 1999) and remains 
in use for structural analysis of changes in the lamina cribrosa (Burgoyne et 
al., 2005). Furthermore, the technique can be used in rabbits to induce robust 
increases in IOP 9 (Gherezghiher et al., 1986), though the problem of corneal 
ectasia with substantial IOP increases remains. Since these models require 
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dedicated laser facilities, they remain the preserve of a small number of 
suitably equipped laboratories. 
 
The primate remains an excellent model for mapping structural and 
morphological changes within the retina and optic nerve head. However, it 
has significant drawbacks with regard to mechanistic studies of glaucoma 
pathology. In this respect, rodents present a more tractable model in terms of 
the ability to create genetic constructs or to undertake cost effective studies of 
retinal and optic nerve changes in glaucoma.  Mice can be bred and 
manipulated to enhance or delete the activity of relevant genes – a facility 
which is increasingly available through gene editing techniques for the rat 
(Sander and Joung, 2014).  
 
In the 1980s the role of microparticle occlusion of the TM was revisited, 
with the development of microbeads for use in cell and molecular biology. The 
beads were available in sizes that matched the pores in the TM and the 
demonstration that these could be incorporated in the TM by phagocytosis 
recommended their use for the obstruction of aqueous outflow (Matsumoto 
and Johnson, 1997). For the primate, microbead injections were first used by 
Weber and Zelenak for the induction of experimental glaucoma (Weber and 
Zelenak, 2001). The model generated effective and sustained increases in 
IOP but this required repeat injections (on a weekly basis in many animals) 
since the beads fell within the anterior chamber under the influence of gravity. 
Importantly, IOP increases were seen following partial fills of the anterior 
chamber thereby maintaining a clear visual axis for fundus imaging. The 
downside of this model is that it generates IOP spikes which could complicate 
the correlation of IOP elevation with retinal ganglion cell damage; clinical 
studies have suggested that spiking IOPs are an independent variable in the 
progression of glaucoma damage (Asrani et al., 2000). An important technical 
consideration was that the microbeads had to be thoroughly washed prior to 
injection to prevent preservative agents in the bead carrier solutions from 
causing anterior chamber inflammation (Weber pers. communication). 
Sterilisation of the beads by gamma irradiation was used to guard against 
endophthalmitis. 
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3.0 Mouse 
 The small anterior chamber of the rodent eye is ideal for microbead 
occlusion. The mouse has particular appeal because of the availability of 
numerous genetic constructs and the ability to measure IOP in awake 
(manually or by telemetry (Ruixia, 2008)) and anaesthetized animals (Wang et 
al., 2005; Cone et al., 2012). 
 
The use of microbeads in mouse glaucoma models has generated a 
wide range of injection parameters and techniques which are summarized in 
table 1. The table is not intended as an exhaustive list of microbead glaucoma 
models but to illustrate the range of injection parameters and IOP elevation. 
Direct comparison between models is difficult because of the lack of 
standardized outcomes but there is a broad consensus that the intraocular 
pressure can be elevated in the mouse eye following one or more anterior 
chamber injections with microbreads. To date, the maximum number of beads 
injected (Frankfort et al., 2013) is as a mixture of 4.7x106 (6µm) and 2.4x107 
(1µm) in 1-2μL (total volume) to generate a mean increase of 15.3(5.6) mmHg 
over a 12 week period following a single injection. By contrast, Sappington, 
used bead numbers 3-4 orders of magnitude lower at 103 beads to produce a 
higher mean IOP of 20.0(0.8) after 2 injections with injection volumes ranging 
from 1-3µl. Cone et al. provided an informative analysis of the effect of mixing 
beads of different sizes on the development of IOP elevation with their ‘4+1’ 
mixture of beads (3x106,6μm + 1.5 x107,1μm) delivering the greatest optic 
nerve damage when measured over a 28 week interval. The choice of bead 
size is an important practical consideration; larger beads are easier to view 
and manipulate but they carry a greater risk of occluding the injection cannula. 
Surprisingly, there does not appear to be a clear relationship between the 
total volume of beads injected and the increase in IOP (Figure 2). Satisfactory 
increases in IOP with similar levels of retinal ganglion cell loss were reported 
in all animals which may reflect the efficiency of using fewer, larger beads. 
Further work with standardized outcome measures would greatly help in the 
selection of the optimum injection parameters.  
Consideration of the volume of the anterior chamber of the mouse eye 
is instructive when considering the optimal injection volume. Functional 
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estimations of the anterior chamber volume for the mouse eye indicate that 
this is approximately 7μl (Zhang et al., 2002). The geometric estimate of 
anterior chamber volume is lower; histological measurements, taking into 
account corneal thickness, corneal curvature and anterior lens curvature give 
the volume of the mouse anterior chamber of 3.94μl (Remtulla and Hallett, 
1985). Cone and Frankfort et al. followed up the bead injections with 3μL of 
viscoelastic which would therefore occupy c. 50-80% of the anterior chamber 
and contribute to an increase in IOP independent of any bead occlusion by 
virtue of its space occupying properties. What is striking is that in the mouse 
eye a 3% increase in anterior chamber volume (7 to 7.2μl) can generate a 
doubling in IOP from 15 to 30mm Hg (Zhang et al., 2002). The extent to which 
the viscosity of the viscoelastic agent alters the stiffness of the cornea has not 
been measured but is a topic worth further investigation since it could 
estimate the accuracy of IOP in these models. 
 
4.0 Rat 
There are advantages to working on rat, rather than mouse glaucoma 
models. Rat eyes are larger and therefore easier to inject and rats can be 
easier to handle in the context of obtaining awake IOP readings. The rat is 
increasingly being used for mechanistic studies of glaucoma pathophysiolgy, 
supported by the increasing availability of genetically altered rats (Ma et al., 
2014). Gene array analyses in wild type strains have been valuable in 
pinpointing potential mechanism for early axonal damage (Johnson et al., 
2011; Agudo et al., 2008). 
Urcola et al. (2006) has provided the most comprehensive review of 
microbead injection protocols in the rat. They compared anterior segment 
injections in Sprague Dawley rats with 10μm latex spheres (table 1) with and 
without the addition of a viscoelastic agent (hydroxypropylmethylcellulose, 
HPM). The maintenance of IOP elevation required multiple anterior segment 
injections (9 injections over 30 weeks) but fewer injections in those eyes 
receiving HPM.  In both sets of eyes with microbead injections, there was a 
tendency for the IOP to increase slowly over time so that the peak IOPs were 
seen at 30 weeks in eyes with HPM injections and at 24 weeks in those eyes 
with beads alone. The level of IOP increase was slightly higher in the HPM 
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injected eyes. The volume of injected agent in both cases was 20μL which is 
a greater proportion of the anterior segment volume for the rat eye compared 
with injections volumes used in the mouse eye (Remtulla and Hallett, 1985). 
The location of the beads is not recorded in this paper- but rats underwent 
fundoscopy prior to sacrifice suggesting that, at least by 30 weeks, the visual 
axis was relatively clear. 
With all bead models, the maintenance of optical clarity is important for 
monitoring retinal health and for the physiological assessment of retinal 
function. No bead models have been used for invasive electrophysiological 
assessment of retinal ganglion cells and the only published study is based on 
an episcleral cautery model (King et al., 2006). It is likely that the majority of 
microbead models result in some obscuration of the visual axis. To minimise 
this effect, Samsel et al. developed a method in which magnetic microspheres 
were injected into the anterior chamber and then relocated to reside within the 
anterior segment thereby minimizing the location of beads over the pupil 
(Samsel et al., 2011). The beads are sterilized by gamma irradiation prior to 
use and result in minimal anterior segment inflammation. Just prior to injection 
they are re-suspended in solution (BSS, Alcon) and then injected using a 32-
33 Gauge needle. A Neodymium Boron (NdB, rare earth) magnet (strength 
c.0.45T) is quite sufficient to relocate the beads. The magnetic flux can be 
shaped to a fine point using a machined soft iron core which can be attached 
to the tip of the magnet to allow for precise location of the beads throughout 
the anterior segment.  
The model has subsequently been used by others to deliver robust and 
prolonged elevations in IOP lasting 2-4 weeks following a single injection 
(Foxton et al., 2013; Dai et al., 2012). A novel refinement has been to place a 
cylindrical magnet (with the magnetic poles at 90 degrees to the axis of the 
cylinder) over the anterior chamber to allow for the rapid transfer of beads to 
the iridocorneal angle (Bunker et al., 2015).  
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5.0 Variables affecting IOP increase 
 
5.1 Cannulation technique 
 Rodents have thin corneas which present a particular challenge for the 
retention of beads. These incisions are more challenging with the rodent eyes 
where the corneal thickness is in the range 160 μm for the rat eye to 90 μm 
for the mouse eye (Bawa et al., 2013). In the mouse, the use of a glass 
injection micropipette is optimal since these can be pulled to very fine outside 
diameters and bevelled to a sharp tip. For 10μm beads, a cannula with an 
external diameter of 100um should facilitate bead retention in the anterior 
chamber and minimise cannula blockage. In some models, the injection site is 
prepared with incision using a larger needle which may compromise bead 
retention. For example Frankfort et al. (2013) made an initial corneal hole with 
a 30G needle which has an external diameter of 300μm (approximately 10% 
of the corneal diameter) followed by the insertion of a 75μm (outside 
diameter) cannula.  These difficulties can be mitigated if the injection track is 
made tangential to the corneal surface (Urcola et al., 2006) to create a self 
sealing incision, a  technique that is routinely used in modern cataract surgery 
(Fine, 1991). In humans, where the corneal stromal thickness is of the order 
of 500μm, a self sealing incision can be constructed simply by traversing the 
corneal thickness. For a 34 guage needle the outside diameter is 190μm 
indicating that the needle can only partially track within the thickness of the 
corneal stroma. The use of tribevelled needles (NanoFil needle, Item#: 
NF34BV-2, World Precision Instruments) can facilitate clean anterior chamber 
injections and these needles can be re-sharpened using a microbeveller. 
With the magnetic bead model, the microbeads can be dissociated 
from the delivery of the carrier solution by gentle angulation of the needle 
within the tunneled incision to facilitate egress of aqueous and carrier solution 
during the injection. Since the beads are drawn away from the injections site 
during this process- microbead loss is minimized. Furthermore, the 
microbeads can be trapped within the iridocorneal angle if the anterior 
chamber is shallowed once the injection has been completed. 
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5.2 Injection time 
 The level of IOP elevation can be shaped by the time course of the 
bead injections. Since this is not systematically recorded for the various 
models comparison between publications can be difficult. The effect of acute 
IOP elevation was explored by Smedwoski et al. (2014) in the rat in which  the 
injection volume of 15μl was injected rapidly over a 5 second period; the 
cornea was noted to be edematous as a result which took approximately 6 
hours to resolve. Optic nerve damage was determined on the basis of axon 
counts and on average was reduced to 30% of control after 6-weeks. The IOP 
increase was estimated at over 55 mmHg for the first port injection day, falling 
to 24mmHg after 6 weeks. The authors used a viscoelastic agent (Microvisc) 
to seal the injection site and reported improved occlusion with a mixture of 
beads (4+1 model) in which 2μl of 6 μm beads was followed by 2μl of 1μm 
beads and then 1ul of Healon. Importantly this protocol generated moderate 
increase in IOP (mean 6.1) but with a mean IOP of 36 mm Hg- typically seen 
at the 7-day period.  
 
5.3 Species differences 
 For the rat, the degree of RGC loss over a 4-6 week period is typically 
20-30% for Brown Norway and Sprague Dawley strains. It is interesting to 
note the high level of damaged noted by Dai et al. (2012) using Albino Swiss 
rats.  
 In the mouse the relationship between strain, IOP elevation and cell 
loss is complicated. The relationship was explored by Cone et al who 
compared the effects of microbead IOP elevation on CD1, DBA/2J and 
C57/B6 young and old mice. They found that the greatest damage to the RGC 
layer occurred in the CD1 (10 months) and young C57/BL6 (2 months) 
animals with relatively little change in the older C57/BL6 (8 months). The lack 
of damage in the elderly eyes is interesting and counterintuitive since the 
physiologic resilience of retinal ganglion cells is likely to reduce with age 
(Baltan et al., 2010). 
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6.0 Conclusion 
 Microbead injection models are in routine use for the development of 
experimental glaucoma in rodents and primates. They allow the generation of 
persistent ocular hypertension and some element of control for the level of 
IOP elevation.  The use of fluorescent markers can greatly facilitate the 
identification of beads within the anterior chamber while the use of 
ferromagnetic particles allows the injection of beads and carrier solution to be 
separated and for a clear visual axis to be maintained. The adjunctive use of 
viscoelastic agents can be useful to position beads within the iridocorneal 
angle; caution should be exercised in their use until more is known of their 
effect on corneal rigidity and, by extension on the accuracy of IOP readings. 
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Table 1 
 
Summary of commonly used microbead models for primate, rat and mouse 
models of glaucoma.
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Author Species vol Viscoelasti
c 
Bead type Bead 
size 
[Bead] IOP max 
(SD) 
(mmHg) 
IOP mean 
(SD) (mmHg) 
Damage (SD) Duration Comment 
Weber & 
Zelenak 
(2001) 
Primate 
(macaq
ue) 
50-
100uL 
NA Latex 
microspheres 
10 um 2-4x105 50.9(17.5) 26.7(7.5) 70% decrease 
in axon count 
30-144 
weeks 
3-12 injections 
per animal 
Cone et 
al. (2012) 
Mouse ‘3+2’ 2uL visco Polystyrene 1.5uL 
6um + 
1.5uL 
1um  
3x106 
6um + 1.5 
x107 1um 
NA 12.9(2.8) 15(24)  28 weeks C57BL/6 
Cone et 
al. (2012) 
Mouse ‘4+1’ 1ul visco Polystyrene 2uL 6um 
+ 2uL 
1um 
3x106 
6um + 1.5 
x107 1um 
NA 18.6(5.1) 36(34) 28 weeks C57BL/6 
Cone et 
al. (2012) 
Mouse ‘2+3’ 3uL Polystyrene 6um 3x106 
6um + 1.5 
x107 1um 
NA 12.5(3.1) 15(24) 28 weeks C57BL/6 
Frankfort 
et al. 
(2013) 
Mouse 
C57BL/
6 
1-2uL 3uL 
Provisc 
Polystyrene 1um + 
6um  
4.7x10^6 
6um + 2.4 
x10^7 
1um 
NA 15.3(5.6) 11.2 (NA) 12 weeks C57BL/6 
Single injection1 
Sappingto
n et al.  
(2010)  
Mouse 
C57BL/
6 
1uL NA Polystyrene 
(fluorescent) 
15um 1x10^3 NA 20.0(0.8) 27%(NA) ON 
counts 
2-4 weeks 100um pipette 
Sappingto
n et al 
(2010) 
Rat 
(BN) 
2-7uL NA Polystyrene 
(fluorescent) 
15um 2.5-
7.0x10^3 
NA 29.7(1.2) 7uL 
28.8 (1.6) 5uL 
26.9 (1.7) 2 uL 
16% (NA) ON 
counts(5uL) 
Up to 8 
weeks  
2nd injection at 2 
weeks 
Urcola et 
al. (2006) 
Rat (SD, 
albino) 
20uL NA Latex 
microspheres 
10 um 2-4x105 37.6(2.6) 28.1 (0.7) 23.1(2)% RGC 
counts 
30 weeks 30 Gauge 
needle: 
tangential 
method: weekly 
Urcola et 
al. (2006) 
Rat (SD, 
Albino) 
10uL 10uL 
hydroxypro
pylemthylce
llulose 
Latex 
microspheres 
10 um 1-2x105 42.5(1.7) 31.1(0.6) 27.2(2.1)% 
RGC counts 
30 weeks 30 Gauge 
needle: 
tangential 
method: weekly 
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*count performed on new bead preparation (4.5 um, Kisker Biotech) 
Samsel et 
al. (2011) 
Rat 
(BN) 
10-
20uL 
NA Polystyrene 
Ferromagnetic 
5um 4.7x10^5* 54(NA) 29.4(0.9) 36.4(2.4) RGC 
layer counts 
6 weeks 32-33 Gauge 
needle 
2 pole magnet 
Dai et al. 
(2012) 
Rat 
(Albino 
Swiss) 
20uL NA Polystyrene 
Ferromagnetic 
(Aldehyde 
terminated) 
5um NA 43(2.3) 36.7 81%  ON 
counts 
4 weeks 33 Gauge 
needle, 2 pole 
magnet 
Foxton et 
al. 
(2013) 
Rat 
(BN) 
25uL NA Polystyrene 
Ferromagnetic 
8um NA 55.2(3.5) 43.3(3.3) x20 increase 
in 
degenerating 
axons 
17 days NA 
Ring magnet 
Smedows
ki et al. 
(2014) 
 
 
Rat 
(Wistar) 
‘10+5’ 5uL visco Polystyrene 5uL 
10um + 
5uL 6um 
NA NA 30.9(3.2) 28% ON 
counts 
6 weeks 22 Gauge 
needle with 
50um glass 
microneedle 
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Figures  
 
 
 
Figure1. A) Diagram and B) image showing injection method; intrastromal 
tunnel incision allows a self-sealing injection. C) Scanning electron 
micrograph of polystyrene ferromagnetic beads. Scale bar: 10μm. D) Soft iron 
head tip for precise redistribution of beads. E) Magnetic manipulation allows 
beads to be drawn into the iridocorneal angle. The disruption of aqueous 
outflow is reduced with maintenance of a clear visual axis. Arrows show 
injection tract. F) Example IOP profiles of two animals following injection of 
magnetic microspheres into the left eye; pressure increase is either moderate 
(top) or acute (bottom) and sustained for 3-4 weeks with a single injection. 
Error bars show SD. 
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Figure2. The injected volume of beads (i.e. without carrier) has little impact on 
the mean IOP achieved in the Mouse (white) and Rat (black). The volume of 
beads delivered varies among methods by up to 3 orders of magnitude. 
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